Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites
NCT03107091
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Cirrhosis
Ascites Hepatic
Interventions
DRUG:
Terlipressin acetate continuous infusion
Sponsor
BioVie Inc.